- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 Aug 2025
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 9 listed it in both
- Shares listed
- 40,636,511
- combined, among listed positions
- Reported value
- $5.4bn
- combined, at the quarter end
Among the 95 comparable managers: 12 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EMR in Q2 2025
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 1,286,755 shares now+548,795
- Davidson Kempner Capital Management LPnew position · 335,000 shares now+335,000
- MFS Investment Managementexisting position · 2,210,059 shares now+243,606
- Freestone Grove Partners LPnew position · 150,222 shares now+150,222
- ExodusPoint Capital Management LPnew position · 29,392 shares now+29,392
Reductions
- Invesco Ltdexisting position · 9,335,823 shares now-1,150,130
- Wellington Management Group LLPexisting position · 14,877,829 shares now-403,121
- AllianceBernstein LPexisting position · 2,379,736 shares now-88,996
New positions and exits
New (5)
Exited (1)
- Maverick Capital Ltdwas $1.2m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 14 | $2.6bn | n.a. | n.a. |
| Q3 2013 | 13 | $3.5bn | n.a. | n.a. |
| Q4 2013 | 16 | $3.8bn | n.a. | n.a. |
| Q1 2014 | 18 | $3.2bn | n.a. | n.a. |
| Q2 2014 | 22 | $3.1bn | n.a. | n.a. |
| Q3 2014 | 18 | $2.7bn | n.a. | n.a. |
| Q4 2014 | 17 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2015 | 20 | $2.5bn | n.a. | n.a. |
| Q3 2015 | 18 | $2.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $2.3bn | n.a. | n.a. |
| Q1 2016 | 16 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 13 | $2.7bn | n.a. | n.a. |
| Q3 2016 | 17 | $3.2bn | n.a. | n.a. |
| Q4 2016 | 16 | $3.0bn | n.a. | n.a. |
| Q1 2017 | 17 | $2.4bn | n.a. | n.a. |
| Q2 2017 | 14 | $2.3bn | n.a. | n.a. |
| Q3 2017 | 14 | $2.4bn | n.a. | n.a. |
| Q4 2017 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q2 2018 | 17 | $2.6bn | n.a. | n.a. |
| Q3 2018 | 16 | $2.9bn | n.a. | n.a. |
| Q4 2018 | 20 | $2.9bn | n.a. | n.a. |
| Q1 2019 | 20 | $2.6bn | n.a. | n.a. |
| Q2 2019 | 15 | $2.5bn | n.a. | n.a. |
| Q3 2019 | 16 | $2.2bn | n.a. | n.a. |
| Q4 2019 | 23 | $3.4bn | n.a. | n.a. |
| Q1 2020 | 17 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 16 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 18 | $2.4bn | n.a. | n.a. |
| Q4 2020 | 18 | $3.5bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.8bn | n.a. | n.a. |
| Q2 2021 | 20 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 17 | $4.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $3.7bn | n.a. | n.a. |
| Q1 2022 | 21 | $3.3bn | n.a. | n.a. |
| Q2 2022 | 24 | $2.8bn | n.a. | n.a. |
| Q3 2022 | 28 | $3.1bn | n.a. | n.a. |
| Q4 2022 | 21 | $4.3bn | n.a. | n.a. |
| Q1 2023 | 26 | $4.3bn | n.a. | n.a. |
| Q2 2023 | 24 | $4.1bn | n.a. | n.a. |
| Q3 2023 | 20 | $3.8bn | n.a. | n.a. |
| Q4 2023 | 18 | $3.5bn | 10 | 8 |
| Q1 2024 | 19 | $4.1bn | 11 | 8 |
| Q2 2024 | 24 | $4.3bn | 15 | 8 |
| Q3 2024 | 14 | $3.8bn | 7 | 6 |
| Q4 2024 | 10 | $4.1bn | 4 | 9 |
| Q1 2025 | 11 | $4.0bn | 9 | 2 |
| Q2 2025 | 16 | $5.4bn | 12 | 4 |
| Q3 2025 | 13 | $4.7bn | 6 | 8 |
| Q4 2025 | 14 | $4.5bn | 16 | 16 |
| Q1 2026 | 16 | $4.6bn | 16 | 15 |
| Q2 2026 | 14 | $4.7bn | 14 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EMR and GE →EMR and LRCX →EMR and GEV →Choose a stock to compare with EMR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EMR, latest filings →Back to the 13F Explorer →